Department of Angiology & Blood Coagulation Marino Golinelli, University Hospital S. Orsola-Malpighi, Via Albertoni, 15 Bologna, Italy.
Eur J Vasc Endovasc Surg. 2010 Mar;39(3):356-65. doi: 10.1016/j.ejvs.2009.11.022. Epub 2010 Jan 19.
This study aims to assess the predictive value of residual venous obstruction (RVO) for recurrent venous thrombo-embolism (VTE) in a study using D-dimer to predict outcome.
This is a multicentre randomised open-label study.
Patients with a first episode of idiopathic VTE were enrolled on the day of anticoagulation discontinuation when RVO was determined by compression ultrasonography in those with proximal deep vein thrombosis (DVT) of the lower limbs. D-dimer was measured after 1 month. Patients with normal D-dimer did not resume anticoagulation while patients with abnormal D-dimer were randomised to resume anticoagulation or not. The primary outcome measure was recurrent VTE over an 18-month follow-up.
A total of 490 DVT patients were analysed (after excluding 19 for different reasons and 118 for isolated pulmonary embolism (PE)). Recurrent DVT occurred in 19% (19/99) of patients with abnormal D-dimer who did not resume anticoagulation and 10% (31/310) in subjects with normal D-dimer (adjusted hazard ratio: 2.1; p = 0.02). Recurrences were similar in subjects either with (11%, 17/151) or without RVO (13%, 32/246). Recurrent DVT rates were also similar for normal D-dimer, with or without RVO, and for abnormal D-dimer, with or without RVO.
Elevated D-dimer at 1 month after anticoagulation withdrawal is a risk factor for recurrence, while RVO at the time of anticoagulation withdrawal is not.
本研究旨在评估在使用 D-二聚体预测结局的研究中,残余静脉阻塞(RVO)对复发性静脉血栓栓塞(VTE)的预测价值。
这是一项多中心随机开放标签研究。
在下肢近端深静脉血栓形成(DVT)患者停止抗凝治疗的当天,通过压迫超声检查确定 RVO 后,招募首次发生特发性 VTE 的患者。在 1 个月后测量 D-二聚体。D-二聚体正常的患者不再继续抗凝,而 D-二聚体异常的患者随机分为继续或不继续抗凝。主要观察指标是 18 个月随访期间的复发性 VTE。
共分析了 490 例 DVT 患者(排除了 19 例因不同原因和 118 例单纯肺栓塞(PE))。D-二聚体异常且未继续抗凝的患者中有 19%(19/99)发生复发性 DVT,D-二聚体正常的患者中有 10%(31/310)发生复发性 DVT(调整后的危险比:2.1;p=0.02)。有或无 RVO 的患者中复发性 DVT 的发生率相似(11%,17/151;13%,32/246)。D-二聚体正常且有或无 RVO、D-二聚体异常且有或无 RVO 的患者中复发性 DVT 的发生率也相似。
抗凝治疗停止后 1 个月 D-二聚体升高是复发的危险因素,而抗凝治疗停止时的 RVO 不是。